11-62782724-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006473.4(TAF6L):c.859C>A(p.Gln287Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000282 in 1,612,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006473.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF6L | NM_006473.4 | c.859C>A | p.Gln287Lys | missense_variant | Exon 9 of 11 | ENST00000294168.8 | NP_006464.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF6L | ENST00000294168.8 | c.859C>A | p.Gln287Lys | missense_variant | Exon 9 of 11 | 1 | NM_006473.4 | ENSP00000294168.3 | ||
TMEM223 | ENST00000528367.1 | c.314-8059G>T | intron_variant | Intron 1 of 2 | 2 | ENSP00000431804.1 | ||||
TMEM223 | ENST00000527073.1 | n.66-8059G>T | intron_variant | Intron 1 of 3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000282 AC: 43AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000278 AC: 70AN: 251410Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135876
GnomAD4 exome AF: 0.000282 AC: 412AN: 1460134Hom.: 0 Cov.: 31 AF XY: 0.000290 AC XY: 211AN XY: 726372
GnomAD4 genome AF: 0.000282 AC: 43AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000268 AC XY: 20AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.859C>A (p.Q287K) alteration is located in exon 9 (coding exon 8) of the TAF6L gene. This alteration results from a C to A substitution at nucleotide position 859, causing the glutamine (Q) at amino acid position 287 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at